Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors ; volume:5 ; number:11 ; day:15 ; month:10 ; year:2024 ; pages:1681-1696 ; date:11.2024
Nature cancer ; 5, Heft 11 (15.10.2024), 1681-1696, 11.2024

Classification: Medizin, Gesundheit

Creator: Burr, Risa
Leshchiner, Ignaty
Costantino, Christina L.
Blohmer, Martin
Sundaresan, Tilak
Cha, Justin
Seeger, Karsen
Guay, Sara
Danysh, Brian P.
Gore, Ira
Jacobs, Raquel A.
Slowik, Kara
Utro, Filippo
Rhrissorrakrai, Kahn
Levovitz, Chaya
Barth, Jaimie L.
Dubash, Taronish
Chirn, Brian
Parida, Laxmi
Sequist, Lecia V.
Lennerz, Jochen K.
Mino-Kenudson, Mari
Maheswaran, Shyamala
Naxerova, Kamila
Getz, Gad
Haber, Daniel A.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s43018-024-00840-y

URN: urn:nbn:de:101:1-2502082202179.710312145385

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Burr, Risa
Leshchiner, Ignaty
Costantino, Christina L.
Blohmer, Martin
Sundaresan, Tilak
Cha, Justin
Seeger, Karsen
Guay, Sara
Danysh, Brian P.
Gore, Ira
Jacobs, Raquel A.
Slowik, Kara
Utro, Filippo
Rhrissorrakrai, Kahn
Levovitz, Chaya
Barth, Jaimie L.
Dubash, Taronish
Chirn, Brian
Parida, Laxmi
Sequist, Lecia V.
Lennerz, Jochen K.
Mino-Kenudson, Mari
Maheswaran, Shyamala
Naxerova, Kamila
Getz, Gad
Haber, Daniel A.
SpringerLink (Online service)

Other Objects (12)

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Hochschulschrift

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Hochschulschrift

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Hochschulschrift

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report

Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Somatic mosaicism in the diseased brain

Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy

Related objects

Reset password